BEXTRA Lawyers - Side Effects, Recall, Lawsuit
  HOME   ABOUT US   BEXTRA RESOURCES   FAQ's BEXTRA NEWS CONTACT US July 29, 2010
Small Business Lawyers Image
 
 
Selecting an attorney for your legal case is a very important decision. Please enter a zip code to find an attorney in your area:
 
  More Product Liability
 

Toxic epidermal necrolysis (Lyell syndro...


< Back to Previous Page

Article Summary: Toxic epidermal necrolysis is perhaps the most formidable disease encountered by dermatologists.

Toxic epidermal necrolysis (Lyell syndrome)



Toxic epidermal necrolysis is perhaps the most formidable disease encountered by dermatologists. Uncommon but not rare, toxic epidermal necrolysis occurs in 60 to 70 persons per year in France. It remains as puzzling a disorder as it was 34 years ago, when described by Lyell.

Whether or not toxic epidermal necrolysis is the most severe form of erythema multiforme is still the subject of discussion.
The physiopathologic events that lead to this rapidly extensive necrosis of the epidermis are not understood.

Indirect evidence suggests a hypersensitivity reaction, but the search for potential immunologic mechanisms has resulted in little data to support this hypothesis.

Accumulated clinical evidence points to drugs as the most important, if not the only, cause of toxic epidermal necrolysis. Sulfonamides, especially long-acting forms, anticonvulsants, nonsteroidal anti-inflammatory agents, and certain antibiotics are associated with most cases of toxic epidermal necrolysis.

Many other drugs have been implicated in isolated case reports. All organs may be involved either by the same process of destruction of the epithelium as observed in the epidermis or by the same systemic consequences of "acute skin failure" as seen in patients with widespread burns. Sepsis is the most important complication and cause of death.

Approximately 20% to 30% of all patients with toxic epidermal necrolysis die.

Elderly patients and patients with extensive lesions have a higher mortality rate. Surviving patients completely heal in 3 to 4 weeks, but up to 50% will have residual, potentially disabling ocular lesions.

The prognosis is improved by adequate therapy, as provided in burn units, that is, aggressive fluid replacement, nutritional support, and a coherent antibacterial policy.

Corticosteroids, advocated by some in high doses to halt the "hypersensitivity" process, have been shown in several studies to be detrimental and should be avoided.

 

If you or anyone you know has taken BEXTRA and has experienced the above symptoms or side effects, contact our BEXTRA lawyer and receive a free case evaluation.

 

Latest Bextra News
 
People Who Have Survived A First Heart Attack Have A Higher Risk Of Dying
forwomen.gov, Jun 22, 2006
Cox-2 inhibitors and NSAIDs have been caught in a prolonged furor since September 2004, when the cox-2 Vioxx was withdrawn from the market due to concerns about...
Read more >

Drug Recall On Bextra
ben.omb.delaware.gov, May 24, 2006
Pfizer announced that it has voluntarily stopped the sales of Bextra...
Read more >

More Bextra News & Articles >


 
Regional Resources
 
Search for BEXTRA resources in your State:

Alabama
Missouri
Alaska Montana
Arizona Nebraska
Arkansas Nevada
California New Hampshire
Colorado New Jersey
Connecticut New Mexico
DC New York
Delaware North Carolina
Florida North Dakota
Georgia Ohio
Hawaii Oklahoma
Idaho Oregon
Illinois Pennsylvania
Indiana Rhode Island
Iowa South Carolina
Kansas South Dakota
Kentucky Tennessee
Lousiana Texas
Maine Utah
Maryland Vermont
Mass Virginia
Michigan Washington
Minnesota West Virginia
Mississippi Wisconsin
  Wyoming

Browse Map >
 
     
 
Bextra Hot Topics
 
Bextra Warning
FDA: Bextra Label Update
Bextra® Product Details
Stevens-Johnson Syndrome
Osteoarthritis Information
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Primary Dysmenorrhea
Toxic Epidermal Necrolysis


 
  Bextra Resources  
 
FAQs About Bextra
Recommended Bextra Links
Bextra Audio & Videos
Top 500 Brand Drugs
The US Federal Code
Bextra Laws

More Bextra Resources >

 
  Did You Know?  
   
 
 


Legal Disclaimers

All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on BEXTRA Recalls.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Your access to and use of this website is subject to additional Terms and Conditions.

Local Professional? Generate new business today
Call 866-227-9356 or contact a sales rep


This site is part of the LawFirms.com Network
©2010 ExpertHub, wholly owned subsidiary of MoxyMedia, Inc.